This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Guangzhou Xiangxue Pharmaceutical Co., Ltd., Hangzhou Converd Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Lun Zeng: Innovator in Pharmaceutical Compositions
Introduction
Lun Zeng is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations that enhance the solubility of poorly soluble compounds.
Latest Patents
Lun Zeng holds 2 patents that focus on innovative pharmaceutical compositions. His latest patents include a drug inclusion complex and its preparation method. The first patent describes a pharmaceutical composition that comprises an active component KX2-361 and hydroxylpropoxyl-β-cyclodextrin. This inclusion compound significantly improves the solubility of the poorly soluble drug KX2-361, allowing for the development of both intravenous and oral preparations. The second patent outlines an oral preparation for treating cell proliferation diseases, which also utilizes hydroxylpropoxyl-β-cyclodextrin and KX2-361. This formulation boasts good stability, high safety, excellent absorbability, and economical cost.
Career Highlights
Throughout his career, Lun Zeng has worked with prominent companies in the pharmaceutical industry. He has been associated with Guangzhou Xiangxue Pharmaceutical Co., Ltd. and Hangzhou Converd Co., Ltd. His work in these organizations has contributed to advancements in drug formulation technologies.
Collaborations
Lun Zeng has collaborated with notable professionals in his field, including Shuiping Shi and Qingyong Zhang. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.
Conclusion
Lun Zeng is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of various diseases. His innovative approaches to improving drug solubility demonstrate his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile